Page last updated: 2024-10-31

mianserin and Diseases in Twins

mianserin has been researched along with Diseases in Twins in 1 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Diseases in Twins: Disorders affecting TWINS, one or both, at any age.

Research Excerpts

ExcerptRelevanceReference
"Unipolar depression is also strongly influenced by nongenetic environmental factors (e."2.42[Genetics of depression. Current knowledge and perspectives]. ( Maier, W, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maier, W1

Reviews

1 review available for mianserin and Diseases in Twins

ArticleYear
[Genetics of depression. Current knowledge and perspectives].
    Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2004, Volume: 47, Issue:5

    Topics: Adolescent; Adult; Age Factors; Aged; Antidepressive Agents, Tricyclic; Bipolar Disorder; Depressive

2004